Literature DB >> 24889417

Discrimination by health care workers versus discrimination by others: countervailing forces on HCV treatment intentions.

Loren Brener1, Robyn Horwitz, Courtney von Hippel, Joanne Bryant, Carla Treloar.   

Abstract

Hepatitis C virus (HCV) infection is a major public health burden. Despite recent advances in HCV treatment, uptake remains low, particularly amongst people who inject drugs. HCV-related stigma and discrimination are common, especially within the health care sector. This research examines a more nuanced approach for how HCV-related stigma and discrimination impacts treatment access and uptake. Based on a social identity framework, we explore whether perceived HCV-related discrimination is associated with attempts to remove the stigma of being HCV-positive via HCV treatment intentions. Based on the results of prior research it was also hypothesised that the source of discrimination (health care workers versus others), and whether the discrimination is perceived to be directed to oneself or to the HCV-positive group, will differentially impact treatment intentions. The sample consisted of 416 people living with HCV in New South Wales, Australia, who acquired HCV from injecting drugs. Participants were asked about their experiences of perceived discrimination directed towards themselves versus their HCV-positive group and perceived discrimination within the health care sector. Findings indicate that discrimination towards the self is a more powerful indicator of treatment intentions than discrimination aimed at the HCV-positive group. This finding is consistent with social identity theory suggesting that people from low status groups are motivated to change their stigmatised status when it is possible to do so. The source of the perceived discrimination also matters, however, as participants who report experiencing discrimination from health workers have lowered intentions to engage with HCV treatment in the future. In combination, the results indicate that while perceived discrimination is commonly understood to act as a barrier to treatment uptake, the relationship is actually more complex than previously conceptualised.

Entities:  

Keywords:  hepatitis C; injecting drug use; perceived discrimination; social identity theory; treatment

Mesh:

Year:  2014        PMID: 24889417     DOI: 10.1080/13548506.2014.923103

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  5 in total

1.  Patient Perceptions of Prejudice and Discrimination by Health Care Providers and its Relationship with Mental Disorders: Results from the 2012 Canadian Community Health-Mental Health Survey Data.

Authors:  Kirsten Marchand; Heather Palis; Eugenia Oviedo-Joekes
Journal:  Community Ment Health J       Date:  2015-09-26

2.  Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.

Authors:  Jason Grebely; Julie Bruneau; Jeffrey V Lazarus; Olav Dalgard; Philip Bruggmann; Carla Treloar; Matthew Hickman; Margaret Hellard; Teri Roberts; Levinia Crooks; Håvard Midgard; Sarah Larney; Louisa Degenhardt; Hannu Alho; Jude Byrne; John F Dillon; Jordan J Feld; Graham Foster; David Goldberg; Andrew R Lloyd; Jens Reimer; Geert Robaeys; Marta Torrens; Nat Wright; Icro Maremmani; Brianna L Norton; Alain H Litwin; Gregory J Dore
Journal:  Int J Drug Policy       Date:  2017-07-03

3.  The distribution and socioeconomic burden of Hepatitis C virus in South Australia: a cross-sectional study 2010-2016.

Authors:  Bernard Luke Edmunds; Emma Ruth Miller; George Tsourtos
Journal:  BMC Public Health       Date:  2019-05-08       Impact factor: 3.295

4.  Healthcare stigma and HIV risk among rural people who inject drugs.

Authors:  Hilary L Surratt; Janet K Otachi; Christopher J McLouth; Nikita Vundi
Journal:  Drug Alcohol Depend       Date:  2021-06-25       Impact factor: 4.852

5.  Strengths and Weaknesses in the Risk Management of Blood-Borne Infections: Qualitative Research in Public Health.

Authors:  Anita Gębska Kuczerowska; Artur Błoński; Joanna Kuczerowska; Robert Gajda
Journal:  Int J Environ Res Public Health       Date:  2020-09-12       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.